SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (436)6/29/1998 10:26:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 1722
 
UPI Science News Report: Valigra deaths number 30
Monday June 29 9:36 PM EDT

NEW YORK, June 29 (UPI) - Reports say about 30 men have died and 70 others
have suffered serious adverse reactions after taking the impotence drug Viagra.

The report, first published in the Wall Street Journal, said the nonfatal reactions include
seven heart attacks, eight strokes, four blackouts, and six serious vision problems.

The manufacturer, Pfizer Inc., New York, estimated that 2 million people in the United
States have taken Viagra since it was approved in March. Viagra also has been
approved in Mexico, Brazil, Switzerland, Morocco, and Kuwait.

''If there are only seventy reactions that's pretty good,'' Raymond Woosley, head of
Pharmacology at Georgetown University, told United Press International.

But he added there may be as many as a hundred unreported cases for every one that
is reported to the Food and Drug Administration. And the FDA reports are often
''sketchy,'' says Woosley, who reviewed the reports.

Woosley told UPI that the basic problem for Viagra was its very success. About 50
percent of all drugs must have modifications to their warning labels once they are out in
the market.

''No drug is ever perfectly safe,'' said Woosley.

But in this case, he said, ''So many people are taking so many pills in such a short
time,'' adverse reactions surfaced more quickly than is the case in most drugs.

Woosley is especially concerned with Viagra's potential interaction with various blood
pressure medications. Viagra does lower blood pressure and in combination with
certain other drugs may lower blood pressure too much.

This did not show up with the several thousand who took part in the trials, but it looks
like it is occuring with some of the several million who are taking Viagra on the market.
Many of the reports
Woosley saw mentioned that patients were taking various blood pressure pills.

One drug that should be especially watched if taken along with Viagra is Hytrin, a drug
orginally taken for high blood pressure, but is now used in treating prostate conditions.

Susan Cruzan, a spokesman for the FDA, said the drug is still considered safe and
effective for the intended patient population and that the FDA will continue to monitor
reports.

Mariann Caprino a spokesman for Pfizar told UPI that ''the experiences we're seeing
are in line with what we saw in our clinical trials and the drug remains safe and effective
when used appropriately in
patients who have been properly diagnosed.''

''Yes, there are people who have taken the drug, had sex and died. There's no
definitive link between the deaths and the drug,'' added Caprino.

In fact, people have died of heart attacks during sex long before Viagra was
introduced, Woosley told UPI. But he said no good figures on these types of
non-Viagra deaths are kept, making it difficult to determine Viagra's full impact.

''I can tell you more about how many pieces of baggage were handled by American
Airlines today than I can tell you about the number of heart attacks during sex or the
number of adverse drug reactions,'' said Woosley.

Woosley called for the adoption of a system such as those that are in place in Britain
and France where government employees are paid to discover and report adverse
drug reactions.

(Written by Ed Ungar in Toronto) Copyright 1998 by United Press International All
rights reserved